Authors:
LEONHARDT W
KURKTSCHIEV T
MEISSNER D
LATTKE P
ABLETSHAUSER C
WEIDINGER G
JAROSS W
HANEFELD M
Citation: W. Leonhardt et al., EFFECTS OF FLUVASTATIN THERAPY ON LIPIDS, ANTIOXIDANTS, OXIDATION OF LOW-DENSITY LIPOPROTEINS AND TRACE-METALS, European Journal of Clinical Pharmacology, 53(1), 1997, pp. 65-69
Authors:
ECKEY R
MENSCHIKOWSKI M
LATTKE P
JAROSS W
Citation: R. Eckey et al., MINIMAL OXIDATION AND STORAGE OF LOW-DENSITY LIPOPROTEINS RESULT IN AN INCREASED SUSCEPTIBILITY TO PHOSPHOLIPID HYDROLYSIS BY PHOSPHOLIPASEA(2), Atherosclerosis, 132(2), 1997, pp. 165-176
Authors:
LEONHARDT W
HANEFELD M
MULLER G
HORA C
MEISSNER D
LATTKE P
PAETZOLD A
JAROSS W
SCHROEDER HE
Citation: W. Leonhardt et al., IMPACT OF CONCENTRATIONS OF GLYCATED HEMOGLOBIN, ALPHA-TOCOPHEROL, COPPER, AND MANGANESE ON OXIDATION OF LOW-DENSITY LIPOPROTEINS IN PATIENTS WITH TYPE-I DIABETES, TYPE-II DIABETES AND CONTROL SUBJECTS, Clinica chimica acta, 254(2), 1996, pp. 173-186
Authors:
MENSCHIKOWSKI M
LATTKE P
BERGMANN S
JAROSS W
Citation: M. Menschikowski et al., EXPOSURE OF MACROPHAGES TO PLA2-MODIFIED LIPOPROTEINS LEADS TO CELLULAR LIPID ACCUMULATIONS, Analytical cellular pathology, 9(2), 1995, pp. 113-121
Authors:
MENSCHIKOWSKI M
HEMPEL U
DINNEBIER G
LATTKE P
WENZEL KW
JAROSS W
Citation: M. Menschikowski et al., CHANGES IN EPITOPE EXPOSITION OF APOLIPOPROTEIN-A-I ON THE SURFACE OFHIGH-DENSITY-LIPOPROTEINS AFTER PHOSPHOLIPASE A(2) TREATMENT, Atherosclerosis, 117(2), 1995, pp. 159-167